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BASIC SCIENCE ARTICLE

Evidence of increased hypoxia signaling in fetal liver from
maternal nutrient restriction in mice
Bethany N. Radford1,2 and Victor K. M. Han1,2,3
BACKGROUND: Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is reduced, and offspring from
IUGR pregnancies are at increased risk for type II diabetes as adults. The liver is susceptible to fetal undernutrition experienced by
IUGR infants and animal models of growth restriction. This study aimed to examine hepatic expression changes in a maternal
nutrient restriction (MNR) mouse model of IUGR to understand fetal adaptations that inﬂuence adult metabolism.
METHODS: Liver samples of male offspring from MNR (70% of ad libitum starting at E6.5) or control pregnancies were obtained at
E18.5 and differential expression was assessed by RNAseq and western blots.
RESULTS: Forty-nine differentially expressed (FDR < 0.1) transcripts were enriched in hypoxia-inducible pathways including Fkbp5
(1.6-fold change), Ccng2 (1.5-fold change), Pfkfb3 (1.5-fold change), Kdm3a (1.2-fold change), Btg2 (1.6-fold change), Vhl (1.3-fold
change), and Hif-3a (1.3-fold change) (FDR < 0.1). Fkbp5, Pfkfb3, Kdm3a, and Hif-3a were conﬁrmed by qPCR, but only HIF-2a (2.2fold change, p = 0.002) and HIF-3a (1.3 p = 0.03) protein were signiﬁcantly increased.
CONCLUSION: Although a moderate impact, these data support evidence of fetal adaptation to reduced nutrients by increased
hypoxia signaling in the liver.
Pediatric Research (2020) 87:450–455; https://doi.org/10.1038/s41390-019-0447-z

INTRODUCTION
Intrauterine growth restriction (IUGR) is a pregnancy condition
where fetal growth is suboptimal, resulting in an infant born with
a birth weight <10th percentile.1 Individuals born from pregnancies complicated by IUGR are at increased risk for peri and
postnatal complications and, as adults, are at increased risk for
metabolic disorders.2 Adverse intrauterine conditions may lead to
adaptations to enhance fetal survival but contribute to aberrant
metabolism as adults.2
Hypoxia-inducible factor (HIF) pathway is a cellular response
to enhance survival in adverse conditions, such as hypoxia and
nutritional stress. Under normal physiological conditions, the a
subunit (HIF-1a, HIF-2a, HIF-3a) is posttranslationally hydroxylated
and/or phosphorylated in the cytosol by regulators such as
von Hippel–Lindau (VHL)/U3 ligase complex, factor inhibitor of
hypoxia (FIH), and glycogen synthase kinase 3β (GSK-3β).3–5 These
posttranslational modiﬁcations promote proteasomal degradation.3–5 During cellular stress, reduced hydroxylation and/or
phosphorylation at stabilization sites inhibit recognition by
the proteasome. Stabilization in the cytosol results in increased
dimerization with the HIF-1β subunit. HIF dimers then translocate
to the nucleus and transcriptionally regulate genes containing
hypoxia-responsive elements (HREs).5 HRE-containing genes
are involved in metabolism, cell cycle regulation, and
angiogenesis.4,6
Adaptations in HIF signaling in the placentas from growthrestricted pregnancies or kidney and liver of maternal nutrient
restriction (MNR) IUGR animal models have been documented.7,8
However, others fail to ﬁnd differences in HIF signaling in these
tissues.9,10 Previously, we have shown that MNR results in male

offspring with reduced fetal and adult liver size and increased
hepatic insulin sensitivity in adulthood.11 Here we aimed to
investigate whether HIF signaling has a role in fetal liver
adaptations. Our results suggest that MNR in mice induces
hypoxia-inducible signaling in the fetal liver. Such adaptations to
growth and metabolism in the developing liver may contribute to
long-term metabolic impacts of IUGR.
METHODS
Animals
All animal procedures were approved by the Animal Use
Subcommittee of the University Council on Animal Care at the
University of Western Ontario and were described by Radford and
Han, 2018.11 Brieﬂy, mice were housed in 12-h light and dark cycles.
Virgin 8-week-old CD-1 females were bred, and the presence of a
vaginal plug indicated E0.5. At E6.5, pregnant females received ad
libitum standard chow (control, N = 5) or MNR (N = 5) (70% total
calories) (#F0173, Bio-Serv, Flemington, NJ). At E18.5, dams were
euthanized with CO2 narcosis and pups with cervical dislocation.
Right liver lobes were removed from each pup, snap frozen in liquid
nitrogen, and stored at −80 °C. Male offspring from MNR have been
reported to be more sensitive than females to the long-term
changes in glucose metabolism,12 and only metabolic changes in
males have been investigated previously in this model.11 Male
fetuses were identiﬁed with SRY PCR (forward primer—TGGACTGGTGACAARGCTA, reverse primer—TGGAAGTACAGGTGTGCACTCT) and
used for further analysis.
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RNA isolations
RNA for sequencing was isolated from ten control and ten MNR
livers (two mice per litter). Additional RNA isolations from eight
control and eight MNR littermates (one or two mice per litter)
were used as a validation cohort for real-time PCR. Brieﬂy, the
frozen right liver lobe (30–50 mg for sequencing and 10–15 mg
for real-time PCR) was pulverized with a Bessman Tissue
Pulverizer (Spectrum Laboratories, Rancho Dominguez, CA),
then homogenized with a Brinkman homogenizer Polytron®
3000 for 50 s in 1 mL or 500 μL of ice-cold TRIzol, respectively.
RNA was collected from the homogenate with the PureLink Mini
RNA Kit (Invitrogen, Carlsbad, CA) using the TRIzol Plus RNA
Puriﬁcation Kit protocol provided by the manufacturer. DNA was
degraded with the on-column DNAse I treatment option in the
provided protocol (Roche, DNAseI recombinant, RNAse-Free,
Cat. No. 716728, Mannheim, Germany). RNA was eluted from
the column with 25 μL of UltraPure™ DNase/RNase-Free Distilled
Water (ThermoFisher Scientiﬁc, Cat. No. 10977015, Carlsbad,
CA) after a 5-min on-column incubation. Samples were
aliquoted into smaller volumes and stored at −80 °C until
further studies.
RNA sequencing
RNA/library QC and RNA sequencing was run at McGill University
and Genome Quebec Innovation Centre, Quebec, Canada.
Libraries were generated with the NEBNext® Ultra™ Directional
RNA Library Prep Kit for Illumina® (E7420S, New England
BioLabs, MA, USA). Quality of RNA was veriﬁed on the Agilent
Bioanalyzer (RIN > 7). Single-read 50 bp sequencing was
obtained from a HiSeq 2500 with 17–31M reads per sample
(average depth of 23M). Reads were aligned to the mm9
transcriptome13 with Bowtie214 (90% alignment rate). Aligned
and raw read counts are deposited in NCBI’s Gene Expression
Omnibus (GSE124006).15
Real-time PCR
cDNA was generated with the SuperScript™ IV First-Strand Synthesis
System (Invitrogen, Vilnius, Lithuania) with 1 μg of RNA per reaction
using the concentrations estimated by the Agilent Bioanalyzer.
Taqman assays that covered multiple exons were purchased for
select target genes including: Ccng2 (4448892, Mm00432394_m1),
Btg2
(4453320,
Mm00476162_m1),
Kdm3a
(4448892,
Mm01182127_m1), Fkbp5 (4448892, Mm00487406_m1), Pfkbp3
(4448892, Mm00504650_m1), Hif-3a (Mm00469375_m1), Vhl
(Mm00494137_m1), Hif-1a (Mm00468869_m1), and Hif-2a
(Mm01236112_m1); and endogenous controls Gapdh (4331182,
Mm99999915_g1) and beta actin (4331182, Mm01205647_g1)
(Invitrogen, Vilnius, Lithuania). Reactions were run with diluted
cDNA (1:5) and the TaqMan™ Fast Advanced Master Mix (Invitrogen,
Vilnius, Lithuania) on the ViiA™ 7 (Applied Biosystems, Carlsbad, CA)
fast 384-well block setting according to the manufacturer’s protocol.
Fold change was calculated using the delta delta CT method (ddCT)
and the average CT value of actin and GAPDH as the reference.

Table 1.

Protein isolations
In all, 10–15 mg of tissue was homogenized with 1 mL of ice-cold
1× Cell Lysis buffer (9803 S) from Cell Signaling (Danvers, MA) with
protease inhibitor cocktail 1, 2, and 3 (P1860, P5726, and P0044,
Sigma-Aldrich, St. Louis, MO) for 40 s with a Brinkman homogenizer Polytron® 3000. Lysates were sonicated (F550 Sonic
Dismemberator, Fisher Scientiﬁc, Markham, ON) and then shaken
at 4 °C for 2 h. Cellular debris was removed from lysates by
spinning at 12,000 × g for 10 min and the supernatant was
collected for analysis. Protein concentrations were calculated with
the Bio-Rad Protein Assay (Cat #500–0006, Bio-Rad Laboratories
Inc., Des Plaines, IL) according to the manufacturer’s protocol.
Western blotting
Fifty μg of protein for HIF-2a blots and 25 μg for all other blots
were loaded and run on an 8% polyacrylamide gel. Protein was
transferred to a polyvinylidene diﬂuoride membrane with the
Transblot TurboTM (Bio-Rad Laboratories Inc., Des Plaines, IL).
Membranes were dipped in methanol and then blocked for an
hour at room temperature in 5% milk in TBST (TBS+0.1% tween).
After rinsing 3 times (5 min each) in TBST, primary antibodies were
incubated in 5% bovine serum albumin in TBST overnight
(Table 1). Blots were rinsed 3 times (5 min each) and incubated
with secondary antibodies in 5% milk in TBST for 1 h at room
temperature (Table 1). Blots were imaged with the ClarityTM
Western ECL Substrate (1705061, Bio-Rad Laboratories Inc., Des
Plaines, IL), and band intensities were quantiﬁed using the
Imagelab software® version 5.1 BETA (Bio-Rad Laboratories Inc.,
Des Plaines, IL). As a loading control, all blots were rinsed 3 times
with TBST (5 min each), stripped with 0.5 M sodium hydroxide for
15 min, and re-probed for actin according to the protocol above.
Each target band was normalized to the respective actin and the
control group was used to calculate relative fold changes. KDM3a
was not assessed via western blot because we were not able to
ﬁnd an effective antibody for the mouse fetal liver samples. All
blots were run in triplicate.
Statistical analysis
Samples that contributed more variation than expected to each
group were removed as outliers as described by Gierliński et al.
with the mean+2 times the interquartile range as the threshold.16
Differential expression was detected with a false discovery rate
(FDR) <0.1 with consistency in ≥2 tools (EdgeR,16 DESeq2,17 and
ALDex218) using the default settings in R (version 3.4.3). Optimal
number of clusters were generated with the gap statistic with the
Cluster library (version 2.0.6) and principle component analysis
(PCA) plots were plotted with ggplot2 (version 2.2.1) and ggrepel
(version 0.8.0) in the R console (version 3.3.2 and 3.4.3). Gene
ontology (GO) pathway enrichment was done on the GO Tool
(Panther)19; and KEGG and NCI pathway enrichments were run on
enrichR.20 For quantitative PCR (qPCR) and western blots, unpaired
t tests were used to compare delta CT values or band intensities
on Graphpad Prism (version 5.2).

Western blot antibodies
Target

Primary

Secondary

Company

Source

Cat. no.

Dilution

HIF-2a

Santa Cruz Biotechnology Inc. (Dallas, TX, USA)

Mouse

sc-13596

1:250

HIF-3a

Santa Cruz Biotechnology Inc. (Dallas, TX, USA)

Mouse

sc-390933

1:200

FKBP5
PFKFB3

Santa Cruz Biotechnology Inc. (Dallas, TX, USA)
Cell Signaling (Danvers, MA, USA)

Mouse
Rabbit

sc-271547
13123S

1:200
1:1000

Actin

ThermoFisher Scientiﬁc (Fremont, CA)

Mouse

MS-1295-PCL

1:2000

Mouse IgG

Bio-Rad Laboratories Inc. (Hercules, CA)

—

170–6515

1:10,000

Rabbit IgG

Bio-Rad Laboratories Inc. (Hercules, CA)

—

170–6515

1:10,000

Pediatric Research (2020) 87:450 – 455

Evidence of increased hypoxia signaling in fetal liver from maternal. . .
BN Radford and VKM Han

452

b

a

10

PC2 (7.56%)

PC2 (7.08%)

20
0
–20

0
Control
MNR

–10
–40

–40

–20
20
0
PCI (7.24%)

40

–10 –5 0
5 10
PC1 (8.38%)

15

Fig. 1 Principle component analysis of the top 500 variable genes. Data were transformed with the centered-log ratio (a) and regularized-log
ratio (b). Control N = 9 and maternal nutrient restriction N = 9, 1–2 pups/litter

RESULTS
RNA sequencing data were assessed for sample outliers and gene
distributions among remaining samples.16 One control and one
MNR sample contributed more variance to their respective
maternal nutrient groups than other samples within the group
and were removed from further analysis (Supplementary Fig. S1).
With remaining samples, two distributions of genes were formed
along PC1 (Supplementary Fig. S2). The second distribution
contained genes enriched in GO pathways in neural and epithelial
cell development (Supplementary Table S1), since hepatocyte and
hematopoietic populations are of primary interest in this study
this second distribution of genes was removed from the analysis.
Overall gene expression was explored with PCA plots and
cluster analysis. The optimal number of clusters with the gap
statistic of the centered-log ratio and regularized-log ratio
transformed data was 1. However, k-means clusters with k = 2
resulted in clusters separating based on counts per sample
(Supplementary Fig. S1a and Supplementary Table S2). The PCA
plot of the top 500 variable genes from the centered-log ratio
(Fig. 1a) did not result in separation of samples based on maternal
nutrition. Although the PCA of the top 500 variable genes of the
regularized-log ratio transformed data indicate moderate separation of maternal nutrition along PC1, the ﬁrst component only
explains 8% of the total variance (Fig. 1b). These plots suggest that
overall gene expression was similar between the control and MNR
fetal livers.
Despite similar overall expression, 49 protein-coding genes
were differentially expressed in MNR fetal livers relative to controls
using a FDR cut-off of <0.1 and consistency of two or more tools
(Supplementary Table S3). GO enrichment indicated negative
regulation of transcription from RNA polymerase II promoter in
response to hypoxia as the top pathway when ranked according
to fold enrichment (Cited2 and Vhl) (Fig. 2a). Hypoxia signaling
was also the top pathway enrichment according to combined
scores with KEGG (Fig. 2b) and NCI (Fig. 2c). Additional genes
included in these enrichments are Pfkfb3 and Hif-3a. Investigation
into gene functions of differentially expressed genes indicate
further involvement in cellular response to hypoxia (Fig. 3).
Genes involved in hypoxic regulation of metabolism, cell cycle
regulation, and chronic hypoxia were selected to be validated by
qPCR in a separate validation cohort (Fig. 4). Pfkfb3 transcript was
increased 1.8-fold (p = 0.002) in MNR relative to controls, similar to
the fold change in the RNAseq data of 1.5 (FDR = 1.2 × 10–6).
Fkbp5 and Kdm3a transcripts were also conﬁrmed to be increased
by 1.3- and 1.5-fold (p = 0.03 and 0.02) and similar to sequencing
fold changes of 1.6 and 1.2, respectively (FDR = 0.006 and 0.04).
Lastly, Hif-3a was signiﬁcantly higher by 1.4-fold in the MNR livers
in the validation cohort (p = 0.01), similar to the 1.3-fold increased

initial MNR cohort (FDR = 0.009). Although not signiﬁcant, Ccng2,
which was 1.5-fold higher in the RNAseq data (FDR = 0.0001), was
relatively higher in the MNR fetal livers by 1.4-fold (p = 0.05). Btg2
and Vhl were not signiﬁcantly different in the validation cohort (p
= 0.1 and 0.7). Both Btg2 and Ccng2 had high variation among
MNR offspring and a small fold change relative to controls (<2).
Larger sample sizes could be required to conﬁrm changes in Btg2
and Ccng2 transcripts. Hif-1a and Hif-2a transcripts were not
signiﬁcantly different in the initial MNR cohort, but Hif-1a was 1.3fold decreased in the validation MNR group relative to controls (p
= 0.01).
Protein levels for genes differentially expressed in the validation
cohort were determined by western blots (Fig. 5). Since the HIF
alpha subunits can be regulated posttranscriptionally in response
to cellular stress, the protein levels were also measured. HIF-1a
was not detected in the fetal liver (Supplementary Fig. 3) but HIF2a was increased 2.2-fold in MNR fetuses (p = 0.002). HIF-3a was
also increased by 1.3-fold (p = 0.03) in MNR relative to controls
(Fig. 5a, b). FKBP5 (1.6-fold change, p = 0.09) and PFKFB3 (1.3-fold
change, p = 0.5) protein levels were not signiﬁcantly different
between the maternal nutrient groups (Fig. 5c, d).
DISCUSSION
Fetal growth restriction leads to increased risk for perinatal
complication and changes to adult glucose metabolism in
adults.1,2 Currently, no treatments are available to address these
perinatal and long-term concerns in IUGR infants. Identiﬁcation of
pathways altered in response to restricted growth in utero in
metabolically important tissues, such as the liver, provide potential
targets for therapeutic intervention. HIF signaling is a pathway
that has gained recent attention in growth-restricted offspring;
however, evidence of HIF induction has been conﬂicting and
tissue speciﬁc.8–10 The approach taken in this study was unbiased,
investigating relative transcript levels of all protein-coding genes,
and supports the concept that HIF signaling is induced in the MNR
fetal liver of male offspring from moderate MNR. This underlines
the importance of further studies to determine how hepatic HIF
signaling inﬂuences fetal survival and long-term glucose metabolism in response to fetal undernutrition.
HIF-2a protein was increased in MNR offspring, but HIF-1a was
not detected. Normal development in cells, such as endothelial
cells, involve a switch from HIF-1a to HIF-2a as the primary HRE
transcriptional regulator,21 similar to the transition observed with
chronic hypoxia in cancer cells.22,23 In these tissues, this switch is
thought to occur in part because oxygen tension increases as
organ perfusion during development becomes more efﬁcient. FIH
and prolyl hydroxylases less efﬁciently hydroxylate HIF-2a allowing
Pediatric Research (2020) 87:450 – 455
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Fig. 2 Top 10 gene ontologies (a), KEGG (b), and NCI:Nature (c) gene pathway enrichments with protein-coding genes differentially
expressed between control and maternal nutrient restriction b, c Signiﬁcant pathways are in red and the bar size represents the
combines score
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it to stabilize and accumulate longer than HIF-1a.24,25 In addition,
differential expression of miRNAs can lead to decreased Hif-1a
mRNA stability but not Hif-2a.26 HIF-1a and HIF-2a have both
redundant and non-redundant gene targets that depend on
cellular context and cell type.27 The presence of HIF-2a but not
HIF-1a is likely due to the late-gestational sampling in this study
and duration of hypoxia signaling.
After formation of the liver bud (~E10), hepatoblasts begin to
differentiate into biliary cells and then immature hepatocytes.28
When fetal livers were collected in this study (E18.5),
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differentiation into hepatocytes and hepatic outgrowth would be
occurring and would continue into the perinatal period.28 Studies
in human induced embryonic stem cell liver buds and in the livers
from fetal mice suggest that HIF-1a expression is positively
associated with differentiation into biliary cells and negatively
correlated with differentiation into hepatocytes.29 Conversely, HIF2a regulates proliferation and hepatic outgrowth in zebra ﬁsh.30
Given the distinct roles, disruption in the timing or protein level of
HIFs could alter liver development. Models of MNR, including
ours,11 have demonstrated reduced liver size (Radford and Han,
2018),11 reduced transcription of genes promoting proliferation,
and increased transcription of markers for differentiation.31 While
further studies to characterize temporal changes of HIF signaling
induced by MNR are needed, increased hepatic HIF signaling late
in gestation could indicate altered timing of differentiation and
proliferation during liver development.
Hif-3a mRNA and protein were higher in MNR compared to
controls. Hif-3a mRNA is induced by HIF-1a during chronic hypoxia
and transcriptionally downregulates Hif-1a as a negative feedback
mechanism.32,33 In mice, Hif-3a has three isoforms, a full-length
transcript and two variants, IPAS and NPAS. All three isoforms can
inhibit the transcriptional activity of HIFs by binding with HIF-1β or
HIF-1/2a, preventing dimerization and nuclear translocation.34
Some HIF-3a splice variants can also weakly induce canonical HIF1a target genes.35 Consequently, increased HIF-3a protein could
contribute to moderate differences between control and MNR HIFinduced transcription.
Fkbp5 was also increased at the transcript level and, although
not signiﬁcant, relatively increased at the protein level. FK506binding protein (FKBP5) is induced by chronic hypoxia in adipose
tissue36 and the induction is HIF-2a dependant in hepatocellular
carcinoma cell lines.37 It functions as co-chaperon to HSP90 and as
a scaffold protein. Subsequently, FKBP5 has diverse functions,
including reducing glucocorticoid receptor activity38 and promoting adipocyte differentiation36 and AKT dephosphorylation.39
Other studies have been conducted in cancer cell lines or

adipocytes, but the role in the developing liver in unknown. It is
conceivable that increased FKBP5 transcription could be an
attempt to adjust metabolism and/or cell growth but that is not
sufﬁcient to induce changes at the protein level due to posttranslational regulation. Posttranslational regulation of HIF target
genes such as FKBP5 could also play a role in the maladaptive
response to MNR in the developing liver.
Changes to hypoxia signaling in the liver could be indirect
through placental adaptations. In guinea pigs, MNR results in
increased hypoxyprobe-1 staining in both male and female liver
and kidneys.8 However, no differences were detected in the
placentas.8 Alternatively, MNR causes fetal circulation to distribute
oxygenated blood received from the umbilical cord away from the
liver to the brain.40 MNR could increase HIF signaling in the
developing liver through changes to fetal circulation and/or
nutritional signaling. Further studies into the mechanism of HIF
signaling need to be elucidated. However, increased HIF-induced
transcripts support the concept that MNR results in increased
hypoxia signaling in the fetal liver.
MNR resulted in fetal expression changes in hypoxia-inducible
signaling pathways of E18.5 liver. Although expression changes
were detected, the protein levels of genes induced by HIF
transcription factors were not signiﬁcantly different. Since tissue
hypoxia declines during development,21,29 it is possible that
downstream changes were more evident earlier in liver development. Still, owing to their importance in regulating multipotency,
cell differentiation, and proliferation, HIF-induced transcription
could result in differences in liver maturity and cell populations. In
addition, differential expression of epigenetic regulators such as
KDM3a may prime HRE-containing genes to respond differentially
to aging or nutritional abundance. Evidence of aberrant hypoxia
signaling was evident in growth-restricted mice, but the impact
was moderate that may relate to the duration of nutrient
restriction and the timing of analysis. Differentially expressed
transcripts support the concept that hypoxia signaling may play a
role in growth restriction in response to fetal undernutrition.
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